The Role of the Amyloid Protein Precursor (APP) in Alzheimer's Disease: Does the Normal Function of APP Explain the Topography of Neurodegeneration?

被引:0
|
作者
David H. Small
机构
[1] University of Melbourne,Laboratory of Molecular Neurobiology, Department of Pathology
来源
Neurochemical Research | 1998年 / 23卷
关键词
Alzheimer; dementia; amyloid; neurite; proteoglycan; plaque;
D O I
暂无
中图分类号
学科分类号
摘要
Alzheimer's disease (AD) is the most common form of dementia in the aged population. Early-onset familial AD (FAD) involves mutations in a gene on chromosome 21 encoding the amyloid protein precursor or on chromosomes 14 or 1 encoding genes known as presenilins. All mutations examined have been found to increase the production of amyloidogenic forms of the amyloid protein (Aβ), a 4 kDa peptide derived from APP. Despite the remarkable progress in elucidating the biochemical mechanisms responsible for AD, little is known about the normal function of APP. A model of how APP and Aβ are involved in pathogenesis is presented. This model may explain why certain neuronal populations are selectively vulnerable in AD. It is suggested that those neurons which more readily undergo neuritic sprouting and synaptic remodelling are more vulnerable to Aβ neurotoxicity.
引用
收藏
页码:795 / 806
页数:11
相关论文
共 50 条
  • [41] Alzheimer's disease: Towards therapeutic manipulation of the amyloid precursor protein and amyloid beta-peptides
    Larner, AJ
    Rossor, MN
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (10) : 1115 - 1127
  • [42] Vasopressin and Bradykinin Regulate Secretory Processing of the Amyloid Protein Precursor of Alzheimer's Disease
    Roger M. Nitsch
    Cindy Kim
    John H. Growdon
    Neurochemical Research, 1998, 23 : 807 - 814
  • [43] Vasopressin and bradykinin regulate secretory processing of the amyloid protein precursor of Alzheimer's disease
    Nitsch, RM
    Kim, C
    Growdon, JH
    NEUROCHEMICAL RESEARCH, 1998, 23 (05) : 807 - 814
  • [44] Involvement of amyloid β precursor protein (AβPP) modulated copper homeostasis in Alzheimer's disease
    Bayer, TA
    Multhaup, G
    JOURNAL OF ALZHEIMERS DISEASE, 2005, 8 (02) : 201 - 206
  • [45] Seizure susceptibility in the APP/PS1 mouse' model of Alzheimer's disease and relationship with amyloid β plaques
    Reyes-Marin, Karen E.
    Nunez, Angel
    BRAIN RESEARCH, 2017, 1677 : 93 - 100
  • [46] A possible role for cathepsins D, E, and B in the processing of beta-amyloid precursor protein in Alzheimer's disease
    Mackay, EA
    Ehrhard, A
    Moniatte, M
    Guenet, C
    Tardif, C
    Tarnus, C
    Sorokine, O
    Heintzelmann, B
    Nay, C
    Remy, JM
    Higaki, J
    VanDorsselaer, A
    Wagner, J
    Danzin, C
    Mamont, P
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 244 (02): : 414 - 425
  • [47] Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease
    Wirths, Oliver
    Breyhan, Henning
    Marcello, Andrea
    Cotel, Marie-Caroline
    Brueck, Wolfgang
    Bayer, Thomas A.
    NEUROBIOLOGY OF AGING, 2010, 31 (05) : 747 - 757
  • [48] Platelet-Derived Secreted Amyloid-Precursor Protein-β as a Marker for Diagnosing Alzheimer's Disease
    Marksteiner, Josef
    Humpel, Christian
    CURRENT NEUROVASCULAR RESEARCH, 2013, 10 (04) : 297 - 303
  • [49] Amyloid precursor-like protein 1 accumulates in neuritic plaques in Alzheimer’s disease
    Thomas A. Bayer
    Krzysztof Paliga
    Sascha Weggen
    O. D. Wiestler
    Konrad Beyreuther
    Gerd Multhaup
    Acta Neuropathologica, 1997, 94 : 519 - 524
  • [50] Mutations of beta-amyloid precursor protein alter the consequence of Alzheimer's disease pathogenesis
    Nuo-Min Li
    Ke-Fu Liu
    Yun-Jie Qiu
    Huan-Huan Zhang
    Hiroshi Nakanishi
    Hong Qing
    Neural Regeneration Research, 2019, (04) : 658 - 665